
They Liked Us. We Lost Anyway
5 of 8

The gap between a promising demo and a working relationship is where most innovative sales go to die.
We had the kind of software that made people lean forward.
Clean UX. Intuitive builds. Visual design that reminded you something in clinical trials didn't have to look like it was built in 2009. Our remote patient monitoring solution was purpose-built for decentralized trials.
Then Covid waned. Sites pulled patients back in-house. The window we'd been built for was closing.
My VP saw something the rest of us hadn't. He made a call that changed how I think about selling.
He turned the laptop around.
The pivot that opened the door
Instead of pitching features, we started showing the build. Live. In the room. A SaaS configuration that used to take weeks happening in minutes in front of the customer's eyes.

Nobody in our space was doing that yet.
Innovation teams leaned in. We were even courted as a white-label solution by one of the largest clinical trial software providers in the industry.
The product had cleared the first threshold.
They believed it worked.
But belief isn't adoption.
The gap nobody budgeted for
When deals got serious, customers liked us and had no idea how to implement us.
Not because they weren't smart. Because genuine innovation — the kind that changes how both sides of a relationship operate — requires something no product demo delivers.
It requires people on both sides to admit the current way of doing things has to change.
That's not a software problem. It's a trust problem.

We flagged it internally. Asked Operations to help map the implementation path. Three months later an acquisition arrived — a European CRO with no US expansion plan and no mandate to solve the problem we'd identified.
We were let go.
And as we walked out, the whole team agreed on one thing: management had just released their lead. Not because the product failed. Because nobody owned the conversation that turns a promising relationship into a working one.
What that conversation actually costs — and what it's worth
The case for investing in customer implementation is a case for giving up revenue today in exchange for compounding returns tomorrow.
Hard sell to a CFO looking at Q3. It requires believing that what you learn from one customer's adoption friction will reshape how you sell the next ten.
But here's what that belief is worth:

The customer who successfully adopts becomes your case study. Your referral. Your proof that the product works in the real world. That compounding return — on trust, on pipeline, on the quality of every relationship that follows — is worth more than any deal closed on the back of a dazzling demo.
Don't lose your conversation.
Every warm conversation is a data point. Every implementation challenge is a lesson. Every customer who figures out how to use you is a template for the next one.
The companies that figure out who owns that process — and give them the mandate to prioritize the long conversation over the quick close — end up with something competitors can't replicate.

Not a product. A pipeline of relationships that teach you how to sell.
About the author
I write about how sales is changing and what I think we should do about it. These articles come from real deals, real losses, and two decades of figuring out what actually moves enterprise pipeline. If this was useful, you already have a sense of how I work.
8 Emails on how I think
The work behind the hire

(laughs included)


